Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom.
Nigel SherriffMassimo MirandolaRonaldo SilvaMaddalena CordioliAlexandra SawyerLorenzo GiosAntonella ZorziJorg HuberJaime VeraDaniel RichardsonMohammed Hassan-IbrahimDominika WlazlyValeska PadoveseChristopher BarbaraAnabel DarmaninAaron SchembriCarlos CaceresSilver VargasKarel BlondeelJames KiarieFirdavs KurbonovRosanna W PeelingSoe Soe ThwinIgor Toskinnull nullPublished in: BMC infectious diseases (2024)
Both the Bioline and the Chembio dual POCT for syphilis and HIV had acceptable performance, acceptability and operational characteristics amongst MSM in the PRoSPeRo network. These dual POCTs could serve as a strategic, more cost effective, patient and healthcare provider (HCP) friendly alternative to conventional testing; in clinical and other field settings, especially those in resource-limited settings.